Vladimir Son
About Vladimir Son
Vladimir Son is the Associate Director of Biostatistics at Bristol Myers Squibb with over a decade of experience in the field, having previously held multiple roles at Regeneron Pharmaceuticals, Inc.
Current Role at Bristol Myers Squibb
Vladimir Son serves as the Associate Director of Biostatistics at Bristol Myers Squibb. In this capacity, he brings over a decade of experience in biostatistics to the company, leveraging his extensive background in both academic and industry settings to support the company's statistical needs. His role involves leading biostatistical initiatives, contributing to clinical trial design, and overseeing statistical analyses for pharmaceutical development projects.
Previous Experience at Regeneron Pharmaceuticals
Vladimir Son held multiple roles at Regeneron Pharmaceuticals, Inc. from 2013 to 2020. He began as a Biostatistician in Basking Ridge, where he served for two years. He then progressed to Senior Biostatistician from 2016 to 2018 and subsequently to Principal Biostatistician in 2019. In 2020, he was promoted to Manager, Biostatistics. Throughout his tenure at Regeneron, Son was involved in various statistical analyses and research, contributing to the development and evaluation of pharmaceutical interventions.
Educational Background in Statistics and Mathematics
Vladimir Son has a robust educational foundation in statistics and mathematics. He earned a Doctor of Philosophy (PhD) in Statistics from Bowling Green State University, where he studied from 2009 to 2013. Prior to that, he obtained a Master of Arts (M.A.) in Statistics from the same university, completing his studies in 2008. Son also holds a Bachelor's degree in Mathematics from the National University of Uzbekistan, achieved in 2005.
Early Career and Academic Contributions
Vladimir Son began his career in biostatistics immediately after completing his PhD in Statistics. His initial role as a Biostatistician at Regeneron Pharmaceuticals set the stage for a progressive career in the industry. With a blend of academic and practical experience, Son has fostered a comprehensive perspective on biostatistical methodology and its applications in pharmaceutical research and development.